Derivados de Quinazolina e Quinolina
As quinazolinas e quinolinas são compostos heterocíclicos contendo nitrogénio, com estruturas aromáticas que desempenham um papel fundamental na síntese de fármacos com atividade anticancerígena, antimicrobiana e anti-inflamatória. Os seus derivados apresentam modificações estruturais que otimizam a biodisponibilidade e a seletividade, permitindo o desenvolvimento de novos princípios ativos para diversas aplicações terapêuticas. Estes compostos são utilizados na fabricação de APIs para o tratamento do câncer, infeções, doenças neurodegenerativas e cardiovasculares. Além disso, os derivados de quinazolina e quinolina são essenciais na investigação de inibidores enzimáticos e no desenvolvimento de moléculas bioativas inovadoras.
Na CymitQuimica, oferecemos derivados de quinazolina e quinolina de alta pureza para aplicações em síntese química, desenvolvimento farmacêutico e biotecnologia.
Foram encontrados 65615 produtos de "Derivados de Quinazolina e Quinolina"
Ordenar por
Pureza (%)
0
100
|
0
|
50
|
90
|
95
|
100
Dabigatran Etexilate Mesylate
CAS:Compounds containing an unfused pyridine ring in the structure, nesoiFórmula:C34H41N7O5·CH4O3SCor e Forma:White Off-White Yellow PowderPeso molecular:723.30503Leflunomide Related Compound B (Z)-2-cyano-3-hydroxy-N-(4-(trifluoromethyl)phenyl)but-2-enamide
CAS:Nitrile function compounds, not elsewhere specified or includedFórmula:C12H9F3N2O2Cor e Forma:White Off-White PowderPeso molecular:270.06161Brivaracetam Related Compound B ((R)-2-[(S)-2-Oxo-4-propylpyrrolidin-1-yl]butanamide)
CAS:Lactams, nesoiFórmula:C11H20N2O2Cor e Forma:White Off-White SolidPeso molecular:212.15248Nadolol Related Compound C
Ether-alcohols and their halogenated, sulfonated, nitrated or nitrosated derivatives not elsewhere specified or includedFórmula:C23H28O7Cor e Forma:Off-White SolidPeso molecular:416.1835Sodium Starch Glycolate Type B
CAS:Dextrins, nesoiFórmula:C2H4O3·xNa·xUnspecifiedCor e Forma:Off-White White PowderPeso molecular:515.6862Nadolol
CAS:Aromatic drugs of amino-alcohols, other than those contFórmula:C17H27NO4Cor e Forma:White PowderPeso molecular:309.4 g/mol4'-Hydroxycelecoxib (4-(5-(4-(hydroxymethyl)phenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl)benzenesulfonamide)
CAS:Sulfonamides, nesoiFórmula:C17H14F3N3O3SCor e Forma:White Off-White SolidPeso molecular:397.0708Bis((R)-butyramide) ((R)-2-amino-N-((R)-1-amino-1-oxobutan-2-yl)butanamide)
CAS:Acyclic amides (including acyclic carbamates) and their derivatives and salts thereof, nesoiFórmula:C8H17N3O2Cor e Forma:White Off-White PowderPeso molecular:187.13208Levetiracetam Related Compound A ((S)-N-(1-amino-1-oxobutan-2-yl)-4-chlorobutanamide)
CAS:Acyclic amides (including acyclic carbamates) and their derivatives and salts thereof, nesoiFórmula:C8H15ClN2O2Cor e Forma:White Off-White CrystalsPeso molecular:206.08221Salmeterol Related Compound A (4-[1-Hydroxy-2-(4-phenylbutylamino)ethyl]-2-(hydroxymethyl)phenol 1-hydroxy-2-naphthoate)
CAS:Aromatic amino-alcohol-phenols, aromatic amino-acid-phenols and other aromatic amino compounds with oxygen functionFórmula:C19H25NO3·C11H8O3Cor e Forma:White PowderPeso molecular:315.18344Ondansetron Related Compound C (9-Methyl-1,2,3,9-tetrahydro-4H-carbazol-4-one)
CAS:Heterocyclic compounds with nitrogen hetero-atom(s) only, aromatic or modified aromatic, nesoiFórmula:C13H13NOCor e Forma:White Powder ClumpyPeso molecular:199.09971Carvedilol Related Compound C (1-(9H-Carbazol-4-yloxy)-3-(benzyl(2-(2-methoxyphenoxy)ethyl)amino)propan-2-ol)
CAS:Aromatic or modified aromatic drugs with nitrogen hetero-atom(s) only, not elsewhere specified or includedFórmula:C31H32N2O4Cor e Forma:Off-White PowderPeso molecular:496.23621Aripiprazole Related Compound F (4-(2,3-dichlorophenyl)-1-[4-(2-oxo-1,2,3,4-tetrahydroquinolin-7-yloxy)butyl]piperazin 1-oxide)
CAS:Lactams not elsewhere specified or includedFórmula:C23H27Cl2N3O3Cor e Forma:White Light Yellow PowderPeso molecular:464.39Aripiprazole Hydroxydihydroquinolinone Analog (7-hydroxy-3,4-dihydroquinolin-2(1H)-one)
CAS:Lactams, nesoiFórmula:C9H9NO2Cor e Forma:White Off-White SolidPeso molecular:163.063334-Methylacetophenone (1-(4-Methylphenyl)-1-ethanone (4'-Methylacetophenone))
CAS:Aromatic ketones without other oxygen function, nesoiFórmula:C9H10OCor e Forma:Colorless LiquidPeso molecular:134.07316Dabigatran Etexilate Related Compound C (Ethyl 3-(2-{[(4-{N'-[(2-ethylbutoxy)carbonyl]carbamimidoyl}phenyl)amino]methyl}-1-methyl-N-(pyridin-2-yl)-1H-benzimidazole-5-carboxamido)propanoate)
CAS:Compounds containing an unfused pyridine ring in the structure, nesoiFórmula:C34H41N7O5Cor e Forma:PowderPeso molecular:627.31692Nilotinib Related Compound C (3-Amino-4-methylbenzoic acid)
CAS:Aromatic amino-acids and their esters, other than those containing more than one kind of oxygen function, not elsewhere specified or includedFórmula:C8H9NO2Cor e Forma:White Beige PowderPeso molecular:151.06333Desthiophenerivaroxaban Methylcarbamate Analog (methyl ((2-oxo-3-(4-(3-oxomorpholino)phenyl)oxazolidin-5-yl)methyl)carbamate)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFórmula:C16H19N3O6Cor e Forma:White Off-White SolidPeso molecular:349.12739Naproxen Related Compound G ((R)-2-(6-Methoxynaphthalen-2-yl)propanoic acid)
CAS:Carboxylic acids with additional oxygen function and their anhydrides, halides, peroxides etc not elsewhere specified or includedFórmula:C14H14O3Cor e Forma:PowderPeso molecular:230.09429Paroxetine Hydrochloride
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFórmula:C19H20FNO3·HClH2OCor e Forma:White Off-White Crystalline PowderPeso molecular:329.142724-Phenylbutyl(benzyl)amine hydrochloride (N-benzyl-4-phenylbutan-1-amine, hydrochloride)
CAS:Aromatic monoamines and their derivatives, salts thereof, nesoiFórmula:C17H21N·HClCor e Forma:White Off-White SolidPeso molecular:239.1674Paroxetine Related Compound B ((3S,4R)-3-[(Benzodioxol-5-yloxy)methyl]-4-phenylpiperidine hydrochloride)
Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFórmula:C19H21NO3·HClCor e Forma:White PowderPeso molecular:347.84Atazanavir S,S,S,R-diastereomer (methyl [(5S,10S,11S,14R)-11-benzyl-5-tert-butyl-10-hydroxy-15,15-dimethyl-3,6,13-trioxo-8-[[4-(pyridin-2-yl)phenyl]methyl]-2-oxa-4,7,8,12-tetraazahexadecan-14-yl]carbamate)
CAS:Compounds containing an unfused pyridine ring in the structure, nesoiFórmula:C38H52N6O7Cor e Forma:Pale Yellow SolidPeso molecular:704.87N-Isopropyl Carvedilol (1-(9H-Carbazol-4-yloxy)-3-[[2-(2-methoxyphenoxy)ethyl](1-methylethyl)amino]-2-propanol)
CAS:Heterocyclic compounds with nitrogen hetero-atom(s) only, aromatic or modified aromatic, nesoiFórmula:C27H32N2O4Cor e Forma:Off-White SolidPeso molecular:448.23621Prasugrel Hydrochloride (5-[2-Cyclopropyl-1-(2-fluorophenyl)-2-oxoethyl]-4,5,6,7-tetrahydrothieno[3,2-c]pyridin-2-yl acetate hydrochloride)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFórmula:C20H20FNO3S·HClCor e Forma:White Off-White PowderPeso molecular:409.09147Levetiracetam Related Compound B ((S)-2-aminobutanamide hydrochloride)
CAS:Acyclic amides (including acyclic carbamates) and their derivatives and salts thereof, nesoiFórmula:C4H10N2O·HClCor e Forma:White Cream PowderPeso molecular:102.07931Topiramate
CAS:Sulfonamides used as drugsFórmula:C12H21NO8SCor e Forma:White Off-White Crystalline PowderPeso molecular:339.09879N-Nitroso Carvedilol Solution (1 mL ) (N-(3-((9H-carbazol-4-yl)oxy)-2-hydroxypropyl)-N-(2-(2-methoxyphenoxy)ethyl)nitrous amide)
CAS:Diagnostic or lab reagents on a backing, prepared diagnostic or lab reagents whether or not on a backing, whether or not in the form of kits, nesoiFórmula:C24H25N3O5Cor e Forma:LiquidPeso molecular:435.17942Metoprolol Related Compound B ((+/-)1-Chloro-2-hydroxy-3-[4-(2-methoxyethyl)phenoxy]-propane)
CAS:Ether-alcohols and their halogenated, sulfonated, nitrated or nitrosated derivatives not elsewhere specified or includedFórmula:C12H17ClO3Cor e Forma:Pale Yellow Clear LiquidPeso molecular:244.08662Gefitinib
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFórmula:C22H24ClFN4O3Cor e Forma:White PowderPeso molecular:446.15214-Chloro Omeprazole (2-[(RS)-[4-Chloro-3,5-dimethylpyridin-2-yl)methyl]sulfinyl]-5-methoxy-1H-benzimidazole)
CAS:Compounds containing an unfused pyridine ring in the structure, nesoiFórmula:C16H16ClN3O2SCor e Forma:Off-White SolidPeso molecular:349.06518Metoprolol Dimer (1,3-Bis[4-(2-methoxyethyl)phenoxy]propan-2-ol)
CAS:Ether-alcohols and their halogenated, sulfonated, nitrated or nitrosated derivatives, nesoiFórmula:C21H28O5Cor e Forma:Colorless Light Yellow LiquidPeso molecular:360.19367Leflunomide Tolyl Analog (5-Methyl-N-(4-methylphenyl)-4-isoxazolecarboxamide)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFórmula:C12H12N2O2Cor e Forma:White PowderPeso molecular:216.08988Monoiodoamiodarone ((2-Butylbenzofuran-3-yl){4-[2-(diethylamino)ethoxy]-3-iodophenyl}methanone)
CAS:Aromatic heterocyclic compounds with oxygen hetero-atom(s) only, nesoiFórmula:C25H30INO3Cor e Forma:Colorless Semi-SolidPeso molecular:519.12704Carbomer Homopolymer
CAS:Other acrylic polymers in primary forms (excluding elastomeric)Cor e Forma:White PowderSorafenib Tosylate
CAS:Compounds containing an unfused pyridine ring in the structure, nesoiFórmula:C21H16ClF3N4O3·C7H8O3SCor e Forma:White Brown PowderPeso molecular:636.10572Deschlorosorafenib (N-Methyl-4-[4-[[[[3-(trifluoromethyl)phenyl]amino]carbonyl]amino]phenoxy]-2-pyridinecarboxamide; N-Methyl-4-{4-[3-(3-trifluoromethylphenyl)ureido]phenoxy}picolinamide)
CAS:Compounds containing an unfused pyridine ring in the structure, nesoiFórmula:C21H17F3N4O3Cor e Forma:White Off-White SolidPeso molecular:430.12527Rivaroxaban R-enantiomer ((R)-5-Chloro-N-({2-oxo-3-[4-(3-oxomorpholino)phenyl]oxazolidin-5-yl}methyl)thiophene-2-carboxamide)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFórmula:C19H18ClN3O5SCor e Forma:Yellow White SolidPeso molecular:435.06557Atazanavir Sulfate Valine Analog (methyl ((5S,10S,11S,14S)-11-benzyl-5-(tert-butyl)-10-hydroxy-15-methyl-3,6,13-trioxo-8-(4-(pyridin-2-yl)benzyl)-2-oxa-4,7,8,12-tetraazahexadecan-14-yl)carbamate sulfate)
CAS:Compounds containing an unfused pyridine ring in the structure, nesoiFórmula:C37H50N6O7·H2SO4Cor e Forma:Off-White SolidPeso molecular:690.3741Saxagliptin Related Compound B (Saxagliptin amide analog (1S,3S,5S)-2-{(S)-2-Amino-2-[(1r,3R,5R,7S)-3-hydroxyadamantan-1-yl]acetyl}-2-azabicyclo[3.1.0]hexane-3-carboxamide)
CAS:Heterocyclic compounds with nitrogen hetero-atom(s) only, excluding aromatic or modified aromaticFórmula:C18H27N3O3Cor e Forma:White Fine PowderPeso molecular:333.20524Salmeterol System Suitability (Mixture containing salmeterol xinafoate, salmeterol-N-alkyl and salmeterol related compound H)
Diagnostic or lab reagents on a backing, prepared diagnostic or lab reagents whether or not on a backing, whether or not in the form of kits, nesoiCor e Forma:White PowderParoxetine Related Compound E (4-(4-Fluorophenyl)-1-methyl-1,2,3,6-tetrahydropyridine hydrochloride)
CAS:Compounds containing an unfused pyridine ring in the structure, nesoiFórmula:C12H14FN·HClCor e Forma:White PowderPeso molecular:191.11103Dichlorothienoic Acid (4,5-dichlorothiophene-2-carboxylic acid)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFórmula:C5H2Cl2O2SCor e Forma:Off-White SolidPeso molecular:195.91526Apixaban Related Compound F (Ethyl 1-(4-methoxyphenyl)-6-(4-nitrophenyl)-7-oxo-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine-3-carboxylate)
CAS:Lactams, nesoiFórmula:C22H20N4O6Cor e Forma:Light Brown PowderPeso molecular:436.13828Norepinephrine Bitartrate
CAS:Catecholamine hormones (excluding epinephrine), their derivatives and structural analoguesFórmula:C8H11NO3·C4H6O6·H2OCor e Forma:White Light Grey Crystalline PowderPeso molecular:337.1009Apixaban Related Compound D (N-Formyl-1-(4-methoxyphenyl)-7-oxo-6-[4-(2-oxopiperidin-1-yl)phenyl]-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine-3-carboxamide)
CAS:Lactams, nesoiFórmula:C26H25N5O5Cor e Forma:White Off-White PowderPeso molecular:487.18557Sorafenib Formamide (4-(4-formamidophenoxy)-N-methylpicolinamide)
CAS:Compounds containing an unfused pyridine ring in the structure, nesoiFórmula:C14H13N3O3Cor e Forma:Off-White SolidPeso molecular:271.09569Duloxetine Hydrochloride
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFórmula:C18H19NOS·HClCor e Forma:White Off-White PowderPeso molecular:297.11874Fesoterodine Chloromandelate
CAS:Aromatic amino-alcohol-phenols, aromatic amino-acid-phenols and other aromatic amino compounds with oxygen functionFórmula:C26H37NO3·C8H7ClO3Cor e Forma:White Fine PowderPeso molecular:411.27734Metoprolol Related Compound D ((+/-)N,N-bis-[2-hydroxy-3-[4-(2-methoxyethyl)phenoxy]propyl](1-methylethyl)amine hydrochloride)
CAS:Aromatic amino-alcohol-phenols, aromatic amino-acid-phenols and other aromatic amino compounds with oxygen functionFórmula:C27H41NO6·HClCor e Forma:White PowderPeso molecular:475.29339
![Salmeterol Related Compound A (4-[1-Hydroxy-2-(4-phenylbutylamino)ethyl]-2-(hydroxymethyl)phenol 1…](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F45%2Fthumb-webp%2F1609614.webp&w=3840&q=75)
